Apexus
- Company typePrivate
- Founded2007
- HeadquartersIrving, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
Apexus firmographics
Firmographics- Name
- Apexus
- Legal name
- Apexus, LLC
- Website
- https://340bpvp.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Apexus industry classification
Industry- Product category
- Pharmaceutical Contract Administration
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- 340B Program Administration & Contract Pharmacy Services (HLAFALAL)
- akta.pro secondary industry
- Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price) (HLAIAKAE)
Keywords
Where Apexus is headquartered
LocationHeadquarters
- HQ city
- Irving
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Apexus business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- HRSA Prime Vendor Contract: Apexus serves as the HRSA-contracted Prime Vendor for the 340B Drug Pricing Program under a competitively awarded government contract. The program is voluntary for covered entities and manufacturers. No enrollment fee is charged to eligible covered entities. Revenue is generated through the administrative and service fees associated with the HRSA contract, manufacturer pricing negotiations, and value-added services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Free enrollment for all eligible 340B covered entities |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels9 records
Apexus product offering
Product offeringCore offering
Apexus operates as the HRSA-contracted Prime Vendor for the 340B Drug Pricing Program, negotiating sub-ceiling drug pricing with manufacturers, setting distribution standards across a network of wholesalers and specialty distributors, and delivering education, compliance tools, and technical assistance to safety-net hospitals, government grantee clinics, and other 340B covered entities across the United States. Program participation is free for eligible covered entities, and Apexus also administers the Manufacturer Refund Service, vaccine pricing programs, and the 340B University training and certification programs.
Product overview
Apexus operates the 340B Prime Vendor Program (PVP), a comprehensive platform for managing the federal 340B Drug Pricing Program under contract with HRSA. The core offering includes negotiated manufacturer discounts, a distribution network, and compliance support. The product portfolio comprises the core PVP platform, supplemented by education services (340B University), technical support (Apexus Answers), the Manufacturer Refund Service, vaccine pricing programs, compliance tools (340B Tools), and state-specific Medicaid profiles. Additional offerings include the Advanced 340B Operations Certificate Program for professional certification and the Covered Entity Refund Service.
Differentiator
Problem solved
Functional benefit
Brands
- Apexus Answers: A national call center providing 340B information support, recognized by 2024 Stevie Awards for customer satisfaction
- 340B University
- 340B ACEs (Apexus Certified Experts)
- Covered Entity Refund Service
Products and services
- 340B Prime Vendor Program (PVP)
- Apexus Answers
- 340B University
- Manufacturer Refund Service
- Advanced 340B Operations Certificate Program (340B ACEs)
- PVP Vaccine Program
- 340B Medicaid Profiles
Quantifiable outcome
- Over $486 million in manufacturer refunds returned to covered entities since inception
- +2 more outcomes
Companies that use Apexus
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles4 records
Apexus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Apexus partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- Hercules PharmaceuticalsminorHercules Pharmaceuticals was approved as an authorized distributor in the Apexus 340B Prime Vendor Program in December 2025. This approval expands the distribution network available to PVP participants for accessing 340B drug products through authorized channels.
- 340B CoalitioncoreApexus partners with the 340B Coalition to deliver 340B University programming at the annual 340B Coalition Summer Conference in National Harbor, MD (July 12-15, 2026). The Coalition serves as a key channel for reaching covered entities and delivering education on 340B compliance and program management.
- ASHP (American Society of Health-System Pharmacists)coreApexus delivers 340B University at ASHP Leaders Conference (October 2026, Rosemont, IL) and ASHP Midyear Clinical Meeting (December 2026, Orlando, FL). ASHP is a key professional organization for pharmacists and serves as a major distribution channel for 340B education to pharmacy leaders and buyers.
- NPPA (National Pharmacy Purchasing Association)minorApexus delivers 340B University at the NPPA Annual Conference (August 17-20, 2026, Las Vegas, NV). NPPA serves pharmacy purchasing professionals who are key decision-makers for 340B program participation and purchasing strategy.
- HRSA (Health Resources and Services Administration)coreApexus serves as the Prime Vendor under a contract awarded by HRSA, the federal agency responsible for administering the 340B Drug Pricing Program. HRSA contracts with the prime vendor to provide education, technical assistance, and manufacturer pricing negotiations for all 340B stakeholders. Apexus was selected to continue as the HRSA 340B Prime Vendor following a competitive, open bid process.
- Informa (Medicaid Drug Rebate Program Summit)minorApexus participates in the Informa Medicaid Drug Rebate Program Summit (November 2-5, 2026, Chicago, IL), a major industry event addressing pharmaceutical pricing and rebate programs relevant to 340B stakeholders.
- Becker's HealthcareminorApexus participates in Becker's Annual CEO + CFO Roundtable and Becker's Fall Chief Pharmacy Officer Summit, major healthcare executive conferences covering hospital operations, finance, and pharmacy strategy relevant to 340B program decisions.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Apexus competitors and assessment
Company assessmentDirect peers
- Sentry Data Systems: Acquired by Cencora (formerly AmerisourceBergen), Sentry Data Systems provides 340B program management software and split-billing solutions to hospitals and pharmacies. It is the closest comparable to Apexus on the software-enabled 340B administration side, though Apexus holds the unique Prime Vendor contract.
- Macro Helix: Provides 340B software, split-billing, and contract pharmacy management to covered entities. Competes with Apexus-affiliated tools in the same hospital pharmacy 340B market and serves overlapping covered-entity customers.
- CaptureRx: A 340B solutions provider specializing in contract pharmacy management and reverse-distribution services. Operates in the same 340B TPA/tech ecosystem that complements or substitutes for parts of Apexus's Prime Vendor program.
- Verity Solutions: 340B compliance and split-billing software vendor serving health systems, FQHCs, and contract pharmacies. Comparable to Apexus in the 340B software-administration category, particularly for grantee and hospital covered entities.
- BHM Healthcare Solutions: 340B consulting and program administration firm supporting hospitals, FQHCs, and Ryan White grantees. Comparable in the 340B services and audit/compliance space where Apexus also competes via 340B Tools and Apexus Answers.
- Visante: Specialized pharmacy and 340B consulting firm serving hospitals and health systems. Operates in the same 340B advisory ecosystem that complements Apexus's contract catalog and compliance offerings.
Emerging players
- SunRx: 340B management platform vendor focused on contract pharmacy programs and covered-entity software. A smaller, emerging 340B software participant competing for similar covered-entity relationships.
Broad incumbents
- Cencora (AmerisourceBergen): One of the Big Three US pharmaceutical wholesalers and owner of Sentry Data Systems. Operates as an authorized distributor in Apexus's PVP network while also competing indirectly via its own 340B software and services portfolio.
- Cardinal Health: Major US pharmaceutical wholesaler that participates in the 340B distribution network under Apexus's PVP standards. Comparable as a broad healthcare distribution incumbent with overlapping 340B drug-flow economics.
- McKesson: One of the largest US pharmaceutical wholesalers and authorized 340B distributor. Comparable as a broad healthcare supply-chain incumbent that channels significant 340B drug volume through Apexus's PVP framework.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Apexus social profiles
Digital presenceApexus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Apexus leadership team
Management profileNumber of profiles
Profiles1 record
Apexus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Apexus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Apexus
What does Apexus do?
Apexus operates as the HRSA-contracted Prime Vendor for the 340B Drug Pricing Program, negotiating sub-ceiling drug pricing with manufacturers, setting distribution standards across a network of wholesalers and specialty distributors, and delivering education, compliance tools, and technical assistance to safety-net hospitals, government grantee clinics, and other 340B covered entities across the United States. Program participation is free for eligible covered entities, and Apexus also administers the Manufacturer Refund Service, vaccine pricing programs, and the 340B University training and certification programs.
Is Apexus a public or private company?
Apexus is a private company. It is classified as corporate owned and is currently operating.
When was Apexus founded?
Apexus was founded in 2007. It employs 101 to 250 people.
Where is Apexus based?
Apexus is headquartered in Irving, United States, in the North America region.
How does Apexus make money?
One revenue line is on record: HRSA Prime Vendor Contract.
Who are Apexus's main competitors?
Direct peers on record are Sentry Data Systems, Macro Helix, CaptureRx, Verity Solutions, BHM Healthcare Solutions and Visante. SunRx is listed as an emerging player. Broad incumbents are Cencora (AmerisourceBergen), Cardinal Health and McKesson.
Does Apexus have an API?
No public API is recorded for Apexus.
What industry is Apexus in?
Apexus's product category is Pharmaceutical Contract Administration. Its primary akta.pro industry code is HLAFALAL, 340B Program Administration & Contract Pharmacy Services, with a secondary code of HLAIAKAE, Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price). Its NAICS code is 42421 and its SIC code is 5122.